药物和生物治疗剂的心血管给药 - Suppr

Suppr

超能文献

Cardiovascular delivery of drugs and biotherapeutics.

作者信息

Chorny Michael, Levy Robert J, Golomb Gershon

机构信息

Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.

Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA, 19104, USA.

出版信息

Drug Deliv Transl Res. 2018 Aug;8(4):865-867. doi: 10.1007/s13346-018-0483-y.

DOI:10.1007/s13346-018-0483-y

PMID:29359245

Abstract

摘要

相似文献

Cardiovascular delivery of drugs and biotherapeutics.

Drug Deliv Transl Res. 2018 Aug;8(4):865-867. doi: 10.1007/s13346-018-0483-y.

A novel approach for establishing cardiovascular drug efficacy.

Nat Rev Drug Discov. 2014 Dec;13(12):942. doi: 10.1038/nrd4090-c2. Epub 2014 Nov 14.

Translating molecular target into drug therapy in cardiovascular disease.

Curr Opin Pharmacol. 2008 Apr;8(2):111-3. doi: 10.1016/j.coph.2008.01.009. Epub 2008 Feb 21.

Translational therapeutics at the platelet vascular interface. Introduction.

Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):s3-4. doi: 10.1161/ATVBAHA.108.162198.

ERBB1/EGFR and ERBB2 (HER2/neu)--targeted therapies in cancer and cardiovascular system with cardiovascular drugs.

Int J Cardiol. 2014 Oct 20;176(3):1301-3. doi: 10.1016/j.ijcard.2014.07.161. Epub 2014 Aug 2.

Nanotherapeutic Solutions for Cardiovascular Disease.

Methodist Debakey Cardiovasc J. 2016 Sep;12(3):132-133. doi: 10.14797/mdcj-12-3-132.

Emerging druggable targets for cardiovascular disease.

Curr Opin Pharmacol. 2009 Apr;9(2):81-3. doi: 10.1016/j.coph.2009.02.001. Epub 2009 Mar 9.

Nanomedicine and drug delivery.

Med Clin North Am. 2007 Sep;91(5):863-70. doi: 10.1016/j.mcna.2007.05.005.

Guest Editor John Cooke Offers Expertise and Insight on Nanotherapeutic Solutions for Cardiovascular Diseases.

Methodist Debakey Cardiovasc J. 2016 Sep;12(3):131. doi: 10.14797/mdcj-12-3-131.

Cardiovascular disease drug discovery.

Nat Biotechnol. 1999 Sep;17(9):930-1. doi: 10.1038/12935.

本文引用的文献

Targeting therapeutics to endothelium: are we there yet?

Drug Deliv Transl Res. 2018 Aug;8(4):883-902. doi: 10.1007/s13346-017-0464-6.

Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases.

Drug Deliv Transl Res. 2018 Aug;8(4):868-882. doi: 10.1007/s13346-017-0431-2.

Multifunctional, JNK-inhibiting nanotherapeutics for augmented elastic matrix regenerative repair in aortic aneurysms.

Drug Deliv Transl Res. 2018 Aug;8(4):964-984. doi: 10.1007/s13346-017-0419-y.

Non-polymer drug-eluting coronary stents.

Drug Deliv Transl Res. 2018 Aug;8(4):903-917. doi: 10.1007/s13346-017-0414-3.

Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system.

Drug Deliv Transl Res. 2018 Aug;8(4):954-963. doi: 10.1007/s13346-017-0412-5.

Approaches to prevent bleeding associated with anticoagulants: current status and recent developments.

Drug Deliv Transl Res. 2018 Aug;8(4):928-944. doi: 10.1007/s13346-017-0413-4.

Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine.

Drug Deliv Transl Res. 2018 Aug;8(4):918-927. doi: 10.1007/s13346-017-0409-0.

The role of monocyte subpopulations in vascular injury following partial and transient depletion.

Drug Deliv Transl Res. 2018 Aug;8(4):945-953. doi: 10.1007/s13346-017-0404-5.

Recurrent in-stent restenosis, certainty of its origin, uncertainty about treatment.

Int J Cardiol. 2017 Mar 1;230:91-96. doi: 10.1016/j.ijcard.2016.12.073. Epub 2016 Dec 22.

Resistant in-stent restenosis in the drug eluting stent era.

Catheter Cardiovasc Interv. 2016 Nov;88(5):777-785. doi: 10.1002/ccd.26559. Epub 2016 May 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cardiovascular delivery of drugs and biotherapeutics.

Drug Deliv Transl Res. 2018 Aug;8(4):865-867. doi: 10.1007/s13346-018-0483-y.

A novel approach for establishing cardiovascular drug efficacy.

Nat Rev Drug Discov. 2014 Dec;13(12):942. doi: 10.1038/nrd4090-c2. Epub 2014 Nov 14.

Translating molecular target into drug therapy in cardiovascular disease.

Curr Opin Pharmacol. 2008 Apr;8(2):111-3. doi: 10.1016/j.coph.2008.01.009. Epub 2008 Feb 21.

Translational therapeutics at the platelet vascular interface. Introduction.

Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):s3-4. doi: 10.1161/ATVBAHA.108.162198.

ERBB1/EGFR and ERBB2 (HER2/neu)--targeted therapies in cancer and cardiovascular system with cardiovascular drugs.

Int J Cardiol. 2014 Oct 20;176(3):1301-3. doi: 10.1016/j.ijcard.2014.07.161. Epub 2014 Aug 2.

Nanotherapeutic Solutions for Cardiovascular Disease.

Methodist Debakey Cardiovasc J. 2016 Sep;12(3):132-133. doi: 10.14797/mdcj-12-3-132.

Emerging druggable targets for cardiovascular disease.

Curr Opin Pharmacol. 2009 Apr;9(2):81-3. doi: 10.1016/j.coph.2009.02.001. Epub 2009 Mar 9.

Nanomedicine and drug delivery.

Med Clin North Am. 2007 Sep;91(5):863-70. doi: 10.1016/j.mcna.2007.05.005.

Guest Editor John Cooke Offers Expertise and Insight on Nanotherapeutic Solutions for Cardiovascular Diseases.

Methodist Debakey Cardiovasc J. 2016 Sep;12(3):131. doi: 10.14797/mdcj-12-3-131.

Cardiovascular disease drug discovery.

Nat Biotechnol. 1999 Sep;17(9):930-1. doi: 10.1038/12935.

本文引用的文献

Targeting therapeutics to endothelium: are we there yet?

Drug Deliv Transl Res. 2018 Aug;8(4):883-902. doi: 10.1007/s13346-017-0464-6.

Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases.

Drug Deliv Transl Res. 2018 Aug;8(4):868-882. doi: 10.1007/s13346-017-0431-2.

Multifunctional, JNK-inhibiting nanotherapeutics for augmented elastic matrix regenerative repair in aortic aneurysms.

Drug Deliv Transl Res. 2018 Aug;8(4):964-984. doi: 10.1007/s13346-017-0419-y.

Non-polymer drug-eluting coronary stents.

Drug Deliv Transl Res. 2018 Aug;8(4):903-917. doi: 10.1007/s13346-017-0414-3.

Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system.

Drug Deliv Transl Res. 2018 Aug;8(4):954-963. doi: 10.1007/s13346-017-0412-5.

Approaches to prevent bleeding associated with anticoagulants: current status and recent developments.

Drug Deliv Transl Res. 2018 Aug;8(4):928-944. doi: 10.1007/s13346-017-0413-4.

Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine.

Drug Deliv Transl Res. 2018 Aug;8(4):918-927. doi: 10.1007/s13346-017-0409-0.

The role of monocyte subpopulations in vascular injury following partial and transient depletion.

Drug Deliv Transl Res. 2018 Aug;8(4):945-953. doi: 10.1007/s13346-017-0404-5.

Recurrent in-stent restenosis, certainty of its origin, uncertainty about treatment.

Int J Cardiol. 2017 Mar 1;230:91-96. doi: 10.1016/j.ijcard.2016.12.073. Epub 2016 Dec 22.

Resistant in-stent restenosis in the drug eluting stent era.

Catheter Cardiovasc Interv. 2016 Nov;88(5):777-785. doi: 10.1002/ccd.26559. Epub 2016 May 17.